Paliperidone Palmitate

Azacus Strategy Consultants Pvt. Ltd. is a leading supplier of Paliperidone Palmitate in the market. Paliperidone is the primary active metabolite of risperidone. Its mechanism of action is unknown but it is likely to act through a similar pathway to risperidone. It has been proposed that the drug's therapeutic activity in schizophrenia is mediated through a combination of central dopamine and serotonin receptor antagonism. Paliperidone is also active as an antagonist at alpha 1 and 2 adrenergic receptors and H1 histaminergic receptors. Paliperidone was approved by FDA for the treatment of schizophrenia on December 20, 2006. It is an antipsychotic drug and works by helping to restore the balance of certain natural chemicals (neurotransmitters) in the brain.

Specification

Payment terms - Online payment accepted.